Patients with advanced-stage head and neck squamous cell carcinoma exhibited markedly lower levels of PER1, PER2, and PER3 proteins compared to those with early-stage tumors, and higher levels of these proteins were associated with longer overall and recurrence-free survival. The gene discussed is PER2; the disease is head and neck squamous cell carcinoma.